Atlas Trials

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

Clinical trial NCT04933669 · RECRUITING

Trial details

NCT number
NCT04933669
Sponsor
First Affiliated Hospital of Zhejiang University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Progression-free SurvivalGastrointestinal Stromal TumorNeoadjuvant
Start date
2021-09-07
Primary completion
2029-12-31
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.